increased susceptibility to experimental autoimmune myasthenia gravis_Cd55<tm1Mme>/Cd55<tm1Mme>

http://metadb.riken.jp/0004823I129P2OlaHsdC57BL6Cd55tm1MmeCd55tm1MmeCd55tm1Mme

increased susceptibility to experimental autoimmune myasthenia gravis_Cd55<tm1Mme>/Cd55<tm1Mme>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• CD55 molecule, decay accelerating factor for complement
  http://metadb.riken.jp/db/mgi_rdf/MGI:104850

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cd55<tm1Mme>/Cd55<tm1Mme>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cd55<tm1Mme>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased susceptibility to experimental autoimmune myasthenia gravis
  http://purl.obolibrary.org/obo/MP_0004823

文献

http://purl.org/net/cito/citesAsAuthority

• Feng. Lin, et.al., Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection., The Journal of clinical investigation, 2002, 110
  http://rdf.ncbi.nlm.nih.gov/pubmed/12417565